Bicara Therapeutics BCAX
NASDAQ BCAX
$18.42 +0.07 (+0.41%)
As of: Oct 21, 2026 · 11:16 AM EDT

Bicara Therapeutics (BCAX) Total Non-Current Liabilities (2023 - 2024)

Updated

Bicara Therapeutics' Total Non-Current Liabilities was $18.12 million in Q4 2024, down 95.3% from $382.73 million a year earlier but up 24.0% from the prior quarter.

Analysis

Bicara Therapeutics (BCAX) Total Non-Current Liabilities (2023 - 2024) Analysis & Trends

  • In earlier years, Total Non-Current Liabilities was $382.73 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.26 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 614.28 Bn 532.81 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.23 Bn 476.34 Bn 12.70 Bn 106.45 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.22 Bn 262.21 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.55 Bn 235.23 Bn 12.86 Bn 33.91 Bn
7 Amgen 235.92 Bn 191.31 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 190.78 Bn 164.98 Bn 6.22 Bn 35.10 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn 97.04 Bn
10 Bicara Therapeutics 1.25 Bn -490.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 18.12 Mn
Sep 30, 2024 14.62 Mn
Dec 31, 2023 382.73 Mn
API Access

Bicara Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BCAX&period=max&api_key=YOUR_API_KEY